Clinical Trial Update: Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether vortioxetine improves cognitive dysfunction in patients with major depressive disorder who are in partial or full remission. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED